Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients.
JournalSeminars in Thrombosis and Hemostasis
MetadataShow full item record
- Physiologically-Based Pharmacokinetic Modeling-Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 Treatment.
- Authors: Wang Z, Chan ECY
- Issue date: 2022 Oct
- Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
- Authors: Reis S, Metzendorf MI, Kuehn R, Popp M, Gagyor I, Kranke P, Meybohm P, Skoetz N, Weibel S
- Issue date: 2022 Sep 20
- Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
- Authors: Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM
- Issue date: 2022 Oct 8
- Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week.
- Authors: Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, Martin DT, Sax PE, Dani SS, Ganatra S
- Issue date: 2022 Nov 15
- Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.
- Authors: Sindelar M, McCabe D, Carroll E
- Issue date: 2023 Jan